Welcome to LookChem.com Sign In|Join Free
  • or
bis[2-phenylpyridinato-N,C2']iridium(III) [2,2,6,6-tetramethylheptane-3,5-dionate-O,O] is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

344796-10-7

Post Buying Request

344796-10-7 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

344796-10-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 344796-10-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,4,4,7,9 and 6 respectively; the second part has 2 digits, 1 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 344796-10:
(8*3)+(7*4)+(6*4)+(5*7)+(4*9)+(3*6)+(2*1)+(1*0)=167
167 % 10 = 7
So 344796-10-7 is a valid CAS Registry Number.

344796-10-7Downstream Products

344796-10-7Relevant academic research and scientific papers

Sulfur-Coordinated Organoiridium(III) Complexes Exert Breast Anticancer Activity via Inhibition of Wnt/β-Catenin Signaling

Sun, Qi,Wang, Yi,Fu, Qiuxia,Ouyang, Ai,Liu, Shanshan,Wang, Zhongyuan,Su, Zijie,Song, Jiaxing,Zhang, Qianling,Zhang, Pingyu,Lu, Desheng

, p. 4841 - 4848 (2021)

The sulfur-coordinated organoiridium(III) complexes pbtIrSS and ppyIrSS, which contain C,N and S,S (dithione) chelating ligands, were found to inhibit breast cancer tumorigenesis and metastasis by targeting Wnt/β-catenin signaling for the first time. Treatment with pbtIrSS and ppyIrSS induces the degradation of LRP6, thereby decreasing the protein levels of DVL2, β-catenin and activated β-catenin, resulting in downregulation of Wnt target genes CD44 and survivin. Additionally, pbtIrSS and ppyIrSS can suppress cell migration and invasion of breast cancer cells. Furthermore, both complexes show the ability to inhibit sphere formation and mediate the stemness properties of breast cancer cells. Importantly, pbtIrSS exerts potent anti-tumor and anti-metastasis effects in mouse xenograft models through the blockage of Wnt/β-catenin signaling. Taken together, our results indicate that pbtIrSS has great potential to be developed as a breast cancer therapeutic agent with a novel mechanism.

Screening structure-property correlations and device performance of Ir(iii) complexes in multi-layer PhOLEDs

Tian, Nan,Lenkeit, Daniel,Pelz, Simon,Kourkoulos, Dimitrios,Hertel, Dirk,Meerholz, Klaus,Holder, Elisabeth

, p. 11629 - 11635 (2012/01/12)

The structure-property correlations of a set of heteroleptic red- and green-emitting Ir(iii) complexes with different temperature sensitivities and charge trapping capabilities are described, revealing superb performance in multi-layer phosphorescent organic light-emitting diodes (PhOLEDs) expressed by very high maximum luminous efficiencies up to 36.8 cd A-1. Using 2-phenylpyridine and with 2-(naphthalen-1-yl)pyridine as the CN ligand, the resulting red emitting complex featured a maximum luminous efficiency of 10.8 cd A-1; one of the most excellent device performances within this class of red Ir(iii) emitters.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 344796-10-7